Publications by authors named "Jerome H Check"

Claim this Profile
G
Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With Mifepristone.
Jerome H Check, Diane L Check, Carrie Wilson

Anticancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer.
Jerome H Check, Diane L Check, Trina Poretta DO, Maya Srivastava, Ethan Check

Anticancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators.
Jerome H Check, Trina Poretta, Diane Check, Maya Srivastava

Anticancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years.
Jerome H Check, Diane L Check

Expert Rev Endocrinol Metab· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology.
Lars Björndahl, Christopher L R Barratt, David Mortimer, Ashok Agarwal, Robert J Aitken, Jerome H Check

Hum Reprod· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor.
Jerome H Check, Diane Check

Anticancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
Jerome H Check, Diane L Check

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma.
Jerome H Check, Diane Check, Trina Poretta, Carrie Wilson

Anticancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life.
Jerome H Check, Diane Check, Maya D Srivastava, Trina Poretta, James K Aikins

Anticancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers - A Review.
Jerome H Check, Diane Check

Anticancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point Inhibitor.
Jerome H Check, Diane Check, Trina Poretta

Anticancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of progesterone and the progesterone receptor in cancer.
Jerome H Check

Expert Rev Endocrinol Metab· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term High-quality Survival with Single-agent Mifepristone Treatment Despite Advanced Cancer.
Jerome H Check, Diane Check, Carrie Wilson, Patrice Lofberg

Anticancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofunction of the Sympathetic Nervous System as a Possible Etiologic Cause of Recurrent Aphthous Stomatitis.
Steven I Present, Jerome H Check

Compend Contin Educ Dent· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF).
Rachael A Cohen, Jerome H Check, Michael P Dougherty

J Assist Reprod Genet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence that Mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV.
Jerome H Check, Carrie Wilson, Rachael Cohen, Mojirayo Sarumi

Anticancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mifepristone causing complete remission of rapidly advancing leukemia with measurement of progesterone-induced blocking factor.
Jerome H Check, Diane Check, Rachael Cohen, Mojirayo Sarumi

Anticancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of progesterone and the progesterone receptor in human reproduction and cancer.
Jerome H Check, Rachael Cohen

Expert Rev Endocrinol Metab· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of heparin for preventing miscarriage.
Jerome H Check

Am J Reprod Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live delivery and implantation rates of donor oocyte recipients in their late forties are similar to younger recipients.
Jerome H Check, Theresa Jamison, Diane Check, Jung K Choe, Deanna Brasile

J Reprod Med· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report showing that a woman with ulcerative colitis refractory to standard therapy responded well to the sympathomimetic amine dextroamphetamine sulfate.
Jerome H Check, Brittney Katsoff, Rachael Cohen

Inflamm Bowel Dis· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel highly effective medical treatment of severe treatment refractory Crohn's disease using sympathomimetic amines: case report.
Jerome H Check, Brittney Katsoff, Rachael Cohen

Inflamm Bowel Dis· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.
Jerome H Check, Ebony Dix, Carrie Wilson, Diane Check

Anticancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.
Jerome H Check, Ebony Dix, Rachael Cohen, Diane Check, Carrie Wilson

Anticancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.
Jerome H Check, Lynn Sansoucie, Joshua Chern, Ebony Dix

Anticancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis